Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Ennio Giulio Favalli »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Enik Vajda < Ennio Giulio Favalli < Ennio Lubrano  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000A81 (2014) Ennio Giulio Favalli [Italie] ; Martina Biggioggero [Italie] ; Antonio Marchesoni [Italie] ; Pier Luigi Meroni [Italie]Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
000F97 (2016) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Martina Biggioggero [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Valentina Grossi ; Maria Infantino ; Francesca Meacci ; Mariangela Manfredi ; Serena Guiducci [Italie] ; Silvia Bellando-Randone [Italie] ; Marco Matucci-Cerinic [Italie] ; Rosario Foti [Italie] ; Marcella Di Gangi [Italie] ; Marta Mosca [Italie] ; Chiara Tani [Italie] ; Fabrizio Palmieri [Italie] ; Delia Goletti [Italie]Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
001449 (2017) Sara Monti [Italie] ; Catherine Klersy [Italie] ; Roberto Gorla [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie] ; Raffaele Pellerito [Italie] ; Enrico Fusaro [Italie] ; Giuseppe Paolazzi [Italie] ; Pier Andrea Rocchetta [Italie] ; Ennio Giulio Favalli [Italie] ; Antonio Marchesoni [Italie] ; Roberto Caporali [Italie]Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
001553 (2017) Fabrizio Cantini [Italie] ; Laura Niccoli [Italie] ; Carlotta Nannini [Italie] ; Emanuele Cassarà [Italie] ; Olga Kaloudi [Italie] ; Ennio Giulio Favalli [Italie] ; Andrea Becciolini [Italie] ; Maurizio Benucci [Italie] ; Francesca Li Gobbi [Italie] ; Serena Guiducci [Italie] ; Rosario Foti [Italie] ; Marta Mosca [Italie] ; Delia Goletti [Italie]Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
001611 (2017) Maria Gabriella Raimondo ; Martina Biggioggero ; Chiara Crotti ; Andrea Becciolini [Italie] ; Ennio Giulio Favalli [Italie]Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
001782 (2017) Ennio Giulio Favalli [Italie] ; Maria Gabriella Raimondo [Italie] ; Andrea Becciolini [Italie] ; Chiara Crotti [Italie] ; Martina Biggioggero [Italie] ; Roberto Caporali [Italie]The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives.
001915 (????) Sergio Iannazzo [Italie] ; Maurizio Benucci [Italie] ; Ennio Giulio Favalli [Italie]Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.
001D41 (2019) Martina Biggioggero [Oman] ; Chiara Crotti [Italie] ; Andrea Becciolini [Oman] ; Ennio Giulio Favalli [Oman]Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
002529 (2019) Martina Biggioggero [Italie] ; Andrea Becciolini [Italie] ; Chiara Crotti [Italie] ; Elena Agape [Italie] ; Ennio Giulio Favalli [Italie]Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritis
002A31 (2020) Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]COVID-19 infection and rheumatoid arthritis: Faraway, so close!
002C25 (2020) Francesco Licciardi [Italie] ; Teresa Giani [Italie] ; Letizia Baldini [Italie] ; Ennio Giulio Favalli [Italie] ; Roberto Caporali [Italie] ; Rolando Cimaz [Italie]COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Ennio Giulio Favalli" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Ennio Giulio Favalli" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Ennio Giulio Favalli
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021